4:02 PM ET
8-K
Capital Raise
Yarrow Bioscience Capital Raise of $172M
Yarrow Bioscience entered into an underwriting agreement to sell 5,769,231 shares of common stock at $26.00 per share. The underwriters fully exercised their option to purchase an additional 865,384 shares, bringing the total expected net proceeds to approximately $161.8 million after expenses.
- Value
- $172M
- Counterparty
- Jefferies LLC, TD Securities (USA) LLC and Guggenheim Securities, LLC